h.agyeman

TL2 · Konya

Contributes reviews on supplier material. Based in Konya.

Joined 24 April 2025 · last posted 20h

83Posts here

0Topics

0Solutions

1.9kLikes received

1.1kLikes given

21Badges

238Days visited

4.7kPosts read

Recent activity

Full stream

Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #98 · Compounds › Retatrutide · 27 Jul 2026 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed retatrutide discussion, as opposed to read about it? The thread is long and I cannot…
Why the timeline is on the right and not the left — what changed since Replied, post #82 · Meta › Site feedback · 26 Jul 2026 · 32 likes Picking up post #80: that is the part I would want checked first. Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #80 · Outcomes › Progress reports · 24 Jul 2026 · 4 likes Nothing here is medical advice and a progress report is a description of what happened to one person under uncontrolled conditions. For what it is worth, the same held…
Prescription portability between countries Replied, post #101 · Access › International · 16 Jul 2026 · 0 likes Picking up post #100: that is the part I would want checked first. Customs practice varies between entry points within the same country, which is why two people in the…
How to ask a question when you cannot say why you are asking it Replied, post #42 · Start Here › How to Ask · 16 Jul 2026 · 5 likes A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
Lipid changes during rapid weight loss: the expected trajectory Replied, post #11 · Clinical › Bloodwork · 10 Jul 2026 · 10 likes Coming back to post #9, because the follow-up matters more than the original answer. Something worth flagging about lipid changes during rapid weight: the…
Deletion sequences: expected mass shifts by residue — the long version Replied, post #7 · Analytics › Impurities & related substances · 10 Jul 2026 · 24 likes Agreed on all of that, and I have nothing to add to it.
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #100 · Devices › Syringes & needles · 9 Jul 2026 · 1 like Coming back to post #99, because the follow-up matters more than the original answer. U-100 means the barrel is graduated for a solution containing one hundred units of…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #105 · Start Here › How to Ask · 7 Jul 2026 · 1 like Worth separating two things that post #101 runs together. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #67 · Evidence › Journal club · 29 Jun 2026 · 32 likes On post #63 — agreed on the reasoning, with one qualification. On SURMOUNT-OSA I would separate what is worth knowing from what is worth acting on. The first list is…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #89 · Evidence › Journal club · 12 Jun 2026 · 0 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.…
Racemisation and why it is invisible to a mass measurement Replied, post #60 · Analytics › Impurities & related substances · 12 Jun 2026 · 9 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…